SLC16A3 and lung adenocarcinoma: Analysis of the GSE213102 and GSE222187 datasets revealed that SLC16A3 expression was significantly lower in multiple cisplatin-resistant lung adenocarcinoma cell lines compared to their corresponding parental cells (Figures 11A-D).